NDC 51688-9652 - 4808-20 CONTINUOUS CAUDAL 18G QUINCKE

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC: 51688-9652
Package NDCs from labels: 51688-9652-2
Manufacturer: Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc.
Effective date: 2016-10-17
Current FDA listing: Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date	Type
Epinephrine - Smiths Medical ASD, Inc. \| Hospira, Inc. \| Aplicare, Inc.	Smiths Medical ASD, Inc. \| Hospira, Inc. \| Aplicare, Inc.	2016-10-17	MEDICAL DEVICE

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
EPINEPHRINE	ACTIVE INGREDIENT	YKH834O4BH	4808-20 CONTINUOUS CAUDAL 18G QUINCKE () C47916 [SMITHS MEDICAL ASD, INC.]	1
LIDOCAINE HYDROCHLORIDE ANHYDROUS	ACTIVE INGREDIENT	EC2CNF7XFP	4808-20 CONTINUOUS CAUDAL 18G QUINCKE () C47916 [SMITHS MEDICAL ASD, INC.]	1
POVIDONE-IODINE	ACTIVE INGREDIENT	85H0HZU99M	4808-20 CONTINUOUS CAUDAL 18G QUINCKE () C47916 [SMITHS MEDICAL ASD, INC.]	1
EPINEPHRINE	ACTIVE MOIETY	YKH834O4BH	4808-20 CONTINUOUS CAUDAL 18G QUINCKE () C47916 [SMITHS MEDICAL ASD, INC.]	1
IODINE	ACTIVE MOIETY	9679TC07X4	4808-20 CONTINUOUS CAUDAL 18G QUINCKE () C47916 [SMITHS MEDICAL ASD, INC.]	1
LIDOCAINE	ACTIVE MOIETY	98PI200987	4808-20 CONTINUOUS CAUDAL 18G QUINCKE () C47916 [SMITHS MEDICAL ASD, INC.]	1
ANHYDROUS CITRIC ACID	INACTIVE INGREDIENT	XF417D3PSL	4808-20 CONTINUOUS CAUDAL 18G QUINCKE () C47916 [SMITHS MEDICAL ASD, INC.]	1
CITRIC ACID MONOHYDRATE	INACTIVE INGREDIENT	2968PHW8QP	4808-20 CONTINUOUS CAUDAL 18G QUINCKE () C47916 [SMITHS MEDICAL ASD, INC.]	1
HYDROCHLORIC ACID	INACTIVE INGREDIENT	QTT17582CB	4808-20 CONTINUOUS CAUDAL 18G QUINCKE () C47916 [SMITHS MEDICAL ASD, INC.]	1
NONOXYNOL-9	INACTIVE INGREDIENT	48Q180SH9T	4808-20 CONTINUOUS CAUDAL 18G QUINCKE () C47916 [SMITHS MEDICAL ASD, INC.]	1
Sodium Chloride	INACTIVE INGREDIENT	451W47IQ8X	4808-20 CONTINUOUS CAUDAL 18G QUINCKE () C47916 [SMITHS MEDICAL ASD, INC.]	1
Sodium Hydroxide	INACTIVE INGREDIENT	55X04QC32I	4808-20 CONTINUOUS CAUDAL 18G QUINCKE () C47916 [SMITHS MEDICAL ASD, INC.]	1
SODIUM METABISULFITE	INACTIVE INGREDIENT	4VON5FNS3C	4808-20 CONTINUOUS CAUDAL 18G QUINCKE () C47916 [SMITHS MEDICAL ASD, INC.]	1
SODIUM PHOSPHATE, DIBASIC	INACTIVE INGREDIENT	GR686LBA74	4808-20 CONTINUOUS CAUDAL 18G QUINCKE () C47916 [SMITHS MEDICAL ASD, INC.]	1
Water	INACTIVE INGREDIENT	059QF0KO0R	4808-20 CONTINUOUS CAUDAL 18G QUINCKE () C47916 [SMITHS MEDICAL ASD, INC.]	1

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 89 of 117 · 2,338 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Natrum Muriaticum	SODIUM CHLORIDE	SEVENE USA	11008014-fff6-4d5a-8c5c-a20443d7cc23	2024-01-30	Warnings	Exact identifier unii: 451W47IQ8X
LIDOCAINE HCI	LIDOCAINE HCI	HF Acquisition Co LLC, DBA HealthFirst	8c63be55-5de4-7f72-e053-2995a90a102e	2024-01-30	Warnings, Adverse reactions	Exact identifier unii: V13007Z41A
EPINEPHRINE	EPINEPHRINE	HF Acquisition Co LLC, DBA HealthFirst	c0d1def8-9f47-0d3e-e053-2995a90af955	2024-01-30	Warnings, Adverse reactions	Exact identifier unii: YKH834O4BH
1% LIDOCAINE HCI	1% LIDOCAINE HCI	HF Acquisition Co LLC, DBA HealthFirst	999dd95d-87fe-12c0-e053-2995a90aa9f7	2024-01-30	Warnings, Adverse reactions	Exact identifier rxcui: 1010033 unii: V13007Z41A
LIDOCAINE HYDROCHLORIDE	LIDOCAINE HYDROCHLORIDE	HF Acquisition Co LLC, DBA HealthFirst	c4bf5905-add7-1cb0-e053-2995a90a7334	2024-01-30	Warnings, Adverse reactions	Exact identifier unii: V13007Z41A
LIDOCAINE HYDROCHLORIDE	LIDOCAINE HYDROCHLORIDE	HF Acquisition Co LLC, DBA HealthFirst	c4c0df51-cc37-323d-e053-2995a90a154a	2024-01-30	Warnings, Adverse reactions	Exact identifier unii: V13007Z41A
Lidocaine Hydrochloride and Hydrocortisone Acetate	LIDOCAINE HYDROCHLORIDE AND HYDROCORTISONE ACETATE	Seton Pharmaceuticals	7a664a34-19fd-4a7b-ab4d-11299b32999e	2024-01-30	Warnings, Adverse reactions	Exact identifier unii: V13007Z41A
Lidocaine Hydrochloride and Hydrocortisone Acetate	LIDOCAINE HYDROCHLORIDE AND HYDROCORTISONE ACETATE	Seton Pharmaceuticals	fd6343a9-15a6-4894-b51f-122e4d6dbe79	2024-01-30	Warnings, Adverse reactions	Exact identifier unii: V13007Z41A
Lidocaine Hydrochloride	LIDOCAINE HYDROCHLORIDE	Seton Pharmaceuticals	1c0abe84-5404-404e-b882-e910e4d43ffb	2024-01-30	Warnings, Adverse reactions	Exact identifier unii: V13007Z41A
Lidocaine Hydrochloride and Hydrocortisone Acetate	LIDOCAINE HYDROCHLORIDE AND HYDROCORTISONE ACETATE	Seton Pharmaceuticals	951862db-3a73-4d25-9d5b-e4111833f43b	2024-01-30	Warnings, Adverse reactions	Exact identifier unii: V13007Z41A
Lidocaine Hydrochloride and Hydrocortisone Acetate	LIDOCAINE HYDROCHLORIDE AND HYDROCORTISONE ACETATE	Seton Pharmaceuticals	6aa284d6-0212-4fb5-809d-c721aa6fe2ba	2024-01-30	Warnings, Adverse reactions	Exact identifier unii: V13007Z41A
LIDOCAINE HCI	LIDOCAINE HCI	HF Acquisition Co LLC, DBA HealthFirst	993bc59e-5e71-bd9e-e053-2a95a90af85c	2024-01-28	Warnings, Adverse reactions	Exact identifier unii: V13007Z41A
2% LIDOCAINE HCI	2% LIDOCAINE HCI	HF Acquisition Co LLC, DBA HealthFirst	78d8fb0a-bfae-6599-e053-2991aa0a2e03	2024-01-28	Warnings, Adverse reactions	Exact identifier rxcui: 1010671 unii: V13007Z41A
LIDOCAINE HCl	LIDOCAINE HCL	HF Acquisition Co LLC, DBA HealthFirst	c4c16714-6b1f-857e-e053-2a95a90a74e4	2024-01-28	Warnings, Adverse reactions	Exact identifier unii: V13007Z41A
XYLOCAINE	XYLOCAINE	HF Acquisition Co LLC, DBA HealthFirst	e3b3b462-8f35-68b8-e053-2995a90a6403	2024-01-27	Warnings, Adverse reactions	Exact identifier rxcui: 1010033
LACTATED RINGERS	SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE	HF Acquisition Co LLC, DBA HealthFirst	a14ca7d9-de30-a303-e053-2a95a90a5304	2024-01-27	Warnings, Adverse reactions	Exact identifier unii: 451W47IQ8X
LIDOCAINE HCI	LIDOCAINE HCI	HF Acquisition Co LLC, DBA HealthFirst	c901016e-9293-79dd-e053-2a95a90a0fda	2024-01-27	Warnings, Adverse reactions	Exact identifier unii: V13007Z41A
LIDOCAINE HCl	LIDOCAINE HCL	HF Acquisition Co LLC, DBA HealthFirst	e8bc96bc-7876-4906-e053-2a95a90ae6ba	2024-01-27	Warnings, Adverse reactions	Exact identifier unii: V13007Z41A
LIDOCAINE HCl	LIDOCAINE HCL	HF Acquisition Co LLC, DBA HealthFirst	e39435a3-1f69-78c5-e053-2995a90a7fc3	2024-01-27	Warnings, Adverse reactions	Exact identifier application number: ANDA080408 rxcui: 1737568 unii: V13007Z41A
0.5% LIDOCAINE HCl	0.5% LIDOCAINE HCL	HF Acquisition Co LLC, DBA HealthFirst	e52fe254-8872-35ce-e053-2a95a90a339e	2024-01-27	Warnings, Adverse reactions	Exact identifier rxcui: 1737343 unii: V13007Z41A

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.